Navigation Links
Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate) for Treatment of Osteoarthritis
Date:9/26/2011

oint cartilage and synovial fluid, which acts as both as a lubricant and shock absorber for the knee joint.  The breakdown of the cartilage and synovial fluid causes the bones to rub against each other, causing stiffness, pain and loss of movement in the joint. While there is no cure for OA, current disease management focuses on controlling joint pain and stiffness.  

About Hyalgan

Hyalgan is based on natural hyaluronic acid which is structurally and chemically similar to hyaluronic acid that is present in the knees of healthy individuals.  Hyaluronic acid is a vital natural component of the cartilage and synovial fluid of the knee joint.

"For many years, Hyalgan has served as an important therapeutic option for sufferers of osteoarthritis," said Dr. Frank Kane of Fidia Pharma Inc.  "Its long-established safety and efficacy record has demonstrated its usefulness in relieving the pain of osteoarthritis in patients who do not get relief from simple analgesics, such as acetaminophen, or are unable to tolerate the side effects of non-steroidal anti-inflammatory agents," continued Kane.

The recommended treatment cycle for Hyalgan is five intra-articular injections given once a week for five weeks, although many patients receive significant pain relief after a three-injection regimen consisting of one injection per week for three weeks.  Hyalgan will relieve pain in a many patients for up to six months.  Hyalgan is only approved to relieve knee pain. The FDA has not evaluated Hylagan's safety and efficacy in other joints.  Full prescribing information and important safety information for Hyalgan can be found at http://www.hyalgan.com.

About Fidia Farmaceutici S.p.A

Headquartered in Abano Terme, Northeast Italy, Fidia Farmaceutici S.p.A., has over 50 years of successful R&D and industry experience with biologically active molecules.  As
'/>"/>

SOURCE Fidia Farmaceutici S.p.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HYALGAN® (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici S.p.A.
2. Obecure Executes Licensing and Clinical Supply Agreement With Farmaceutici-Formenti SPA for Extended Release Formulation of Betahistine
3. VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A.
4. OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010
5. CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology
6. Osteotechs MagniFuse(TM) Distributed to 68 U.S. Hospitals as Product Revenue Surpasses $1 Million
7. Par Obtains Exclusive Rights to Market and Distribute Generic Zetia(R) in the U.S.
8. Patient Advocacy Group Distributes Wallet Cards to Help Protect Patients from Medication Switching
9. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
10. Draeger Announces Partnership With L. N. Curtis & sons to Distribute Emergency Responder Equipment
11. As Cholera Outbreak Spreads, World Vision Deploys Teams to Distribute Emergency Health Supplies, Focus on Preventative Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ... "Drug Injection Devices to 2020" report to ... As new drugs become available ... health conditions, drug developers have increasingly pursued packaging ... and increase the efficiency and reliability with which ...
(Date:12/13/2014)...  Radiologists can transmit their reports, which can ... physicians, electronic health records (EHR) systems securely, efficiently, ... That was the message behind a ... the recent Radiology Society of North America Meeting ... in this manner also helps referring physicians satisfy ...
(Date:12/13/2014)... -- Mindray Medical International Limited ("Mindray", NYSE: ... medical devices worldwide, today announced shareholder resolutions adopted at ... Hong Kong on December 10, 2014. ... re-elect incumbent directors Li Xiting and Kern Lim, each ... re-elect Peter Wan as a director. ...
Breaking Medicine Technology:Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
... Grifols, a global healthcare company and biopharmaceutical manufacturer based ... an Expert Advisory Council in Transfusion Medicine drawing on ... across the globe.  The role of the Expert Advisory ... Grifols, own transfusion medicine research and development activities. ...
... CareFusion Corporation (NYSE: CFN ... of Carlos M. Nunez, M.D. as its chief medical officer ... and hospitalist as well as an experienced health care technology ... the areas of clinical effectiveness, information technology, public policy and ...
Cached Medicine Technology:Grifols Establishes Expert Advisory Council in Transfusion Medicine 2Grifols Establishes Expert Advisory Council in Transfusion Medicine 3CareFusion Appoints Carlos M. Nunez, M.D. as Chief Medical Officer 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... , , ABBOTT PARK, Ill., ... goal of a 5 percent reduction in the amount of packaging ... effort to minimize its impact on the environment. To achieve ... of launching, more than 40 sustainable packaging initiatives across its nutrition, ...
... to alleviate the shortage of available liver donors. Accurate estimation ... and recipient is crucial. Scholars of different countries established several ... most accurate for Chinese adults has remained unclear. ... on August 28, 2009 in the World Journal of ...
... type of cellular adaptor protein and transcriptional co-activator. In ... overexpressed and highly activated in hepatic cancers and mammary ... of the inhibitor of apoptotic protein (IAP) family, which ... cell protease receptor-1 in the human genomic library in ...
... Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline,s ... defects, but the world,s second-biggest drugmaker hid its risks to ... , According to available information, Glaxo failed ... Paxil,s risks. The Philadelphia trial is the first of more ...
... Md., Sept. 16 On September 15, 2009, GenVec, Inc. (Nasdaq: ... Market stating that the minimum bid price of the Company,s common ... and that the Company was therefore not in compliance with Marketplace ... on the listing of the Company,s common stock on The NASDAQ ...
... , WEDNESDAY, Sept. 16 (HealthDay News) -- Scientists have long ... But now researchers have found a possible equalizer -- a ... youngest poor kids may be enough to offset negative ... skills, at least up to the fifth grade, according to ...
Cached Medicine News:Health News:Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts 2Health News:Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts 3Health News:Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts 4Health News:Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage 2Health News:GenVec Receives NASDAQ Notice of Minimum Bid Price Non-Compliance 2Health News:GenVec Receives NASDAQ Notice of Minimum Bid Price Non-Compliance 3Health News:Better Day Care, Smarter Kids? 2Health News:Better Day Care, Smarter Kids? 3Health News:Better Day Care, Smarter Kids? 4
Lyphochek Whole Blood Metals Control contains the major heavy metals of toxicological and environmental importance for whole blood analysis....
Lyphochek Whole Blood Control is a unique product designed to monitor immunosuppressants, red cell folate and lead in whole blood assays. This control has three critical levels for each analyte and i...
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis....
Medicine Products: